Brief: Lipac Oncology And Huons Announce Exclusive Licensing Agreement For Tsd-001 In Korea
16/09/2019 14:30
Sept 16 (Reuters) - Huons Co Ltd 243070.KQ :
* LIPAC ONCOLOGY AND HUONS CO. ANNOUNCE EXCLUSIVE LICENSING
AGREEMENT FOR TSD-001 IN KOREA
Source text for Eikon: ID:nPn511Qswa
Further company coverage: 243070.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Huons
See all newsBrief: Huons Q2 Operating Profit 3 Billion Won, Down 77.6% From Year Earlier
Brief: Huons Q4 Operating Profit 9.8 Billion Won, Down 10.6% From Year Earlier
Brief: Huons To Divest 7 Billion Won Worth Of Own Shares
Brief: Huons Q3 Operating Profit 10 Billion Won, Up 13.7% From Year Earlier
Brief: Huons Q1 Operating Profit 12.8 Billion Won, Up 20% From Year Earlier